FDA inspection
Resilience Biotechnologies, Inc.: FDA inspection ending Aug 8, 2018
FDA inspection 1061498 · Voluntary Action Indicated (VAI) · Mississauga
Key facts
| Inspection ID | 1061498 |
|---|---|
| Firm | Resilience Biotechnologies, Inc. |
| FEI number | 3007503037 |
| Address | 2585 Meadowpine Blvd |
| City | Mississauga |
| Fiscal year | 2018 |
| Inspection end date | Aug 8, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data